'Brand Names Of Drugs No Assurance Of Quality, Safety'

Using brand names to prescribe drugs should stop in the interest of public health, says KM Gopakumar, legal researcher and legal advisor on medicine access and intellectual property at Third World Network

Related Keywords

Kerala ,India ,Delhi ,Jan Aushadhi Yojana ,Samsung ,Indian Pharmacopoeia Commission ,Cipla ,National Health Profile ,Competition Commission Of India ,National Sample Survey ,Third World Network ,Pharmacovigilance Program Of India Pv ,World Network ,Health Profile ,Medical Ethics ,Competition Commission ,Pharmacopoeia Commission ,Adverse Drug Reaction ,Public Health ,Eneric Drugs In India ,India Bharat ,Drugs , ,